Algert Global’s Amphastar Pharmaceuticals AMPH Stock Holding History
Bought
Maintained
Sold
Other funds holding AMPH
Algert Global's AMPH Position: Q2 2026 in Review
Algert Global increased its Amphastar Pharmaceuticals (AMPH) stake by 111% in Q2 2026, buying an estimated $1.39M and bringing the position to 131,400 shares worth $2.65M. The position accounts for 0.03% of the portfolio, ranked #770.
Algert Global first reported a position in AMPH in Q3 2016 and has held it in 16 quarters since. The position peaked at $10.5M in Q3 2025. 210 funds tracked by Wall St. Rank hold AMPH as of Q2 2026.
- Algert Global held 131,400 shares of Amphastar Pharmaceuticals worth $2.65M as of Q2 2026.
- Algert Global bought 69,040 Amphastar Pharmaceuticals shares in Q2 2026, an estimated $1.39M.
- Amphastar Pharmaceuticals made up 0.03% of Algert Global's portfolio in Q2 2026, its #770 holding.
- Algert Global first reported a position in Amphastar Pharmaceuticals in Q3 2016 and has held it in 16 quarters since.
- Algert Global's Amphastar Pharmaceuticals position peaked at $10.5M in Q3 2025.
- 210 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2026.
Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.